MedTrace Logo

Electromyographic (EMG) on the Anaesthesia Monitor

NCT01142635 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-06-11

No results posted yet for this study

Summary

Intubation may induce electromyographic (EMG) activity, causing depth of anaesthesia monitors to show misleadingly high values. The investigators want to investigate whether this EMG activity can be visually seen on the anaesthesia monitor.

Conditions

  • Anaesthesia

Interventions

DRUG

Rocuronium bromide

Rocuronium, iv, 0,6 mg/kg diluted with saline to double volume, bolus, single dose

DRUG

Rocuronium bromide

Rocuronium, iv, single dose, single bolus, 1.2 mg/kg

Sponsors & Collaborators

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Arvi Yli-Hankala, MD · Tampere University Hospital

  • Arvi Yli-Hankala, MD · Tampere University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01142635 on ClinicalTrials.gov